Clinical Trial Update: Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and feasibility of combining radiation therapy with doxorubicin in patients with resectable primary or recurrent retroperito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retroperitoneal Soft Tissue Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Sarcoma | Phase 1 | Status: COMPLETED